latest news in companies
Government Pays AT&T Millions to Search Trillions of Domestic Phone Records
Washington, Thursday, 19 November 2026.
Immigration authorities are paying AT&T millions for warrantless access to trillions of domestic phone records, quietly capturing non-customer communications routed across wholesale networks.
Samba TV Bridges Linear and Streaming with New Measurement Tool
San Francisco, Thursday, 19 November 2026.
Samba TV launched a single feed uniting linear television and over 600 streaming apps, eliminating critical industry blind spots by tracking 400 billion monthly media signals across eight countries.
Global Garment Maker Backed by World Bank to Advance Female Leadership in Jordan
Amman, Thursday, 19 November 2026.
Jerash Holdings joined the International Finance Corporation to become Jordan’s first certified textile maker for gender equity, aiming to expand manufacturing and support 10,000 regional jobs.
Rheinmetall Expands Dutch Partnership Despite Severe Stock Slide
The Hague, Thursday, 19 November 2026.
Rheinmetall partnered with the Netherlands to build advanced military vehicles, yet its stock fell further, deepening a steep year-to-date market decline of nearly 55 percent amid widespread investor sell-offs.
Anthropic Shatters IPO Records With a Historic 1.5 Trillion Dollar Market Valuation
New York, Thursday, 19 November 2026.
Anthropic raised over $81 billion in history’s largest public debut, valuing the artificial intelligence leader at $1.5 trillion despite posting a staggering $104 billion nine-month net loss.
Modular Medical Secures Major Insurance Deals for Patch Pump
San Diego, Thursday, 19 November 2026.
Modular Medical secured coverage with the top three U.S. pharmacy benefit managers, opening access to over 182 million insured lives and roughly 80% of domestic prescription claims for its insulin pump.
Biotech Firm Vogenx Secures Spot in Key Russell Benchmarks Just Months Post-IPO
New York, Thursday, 19 November 2026.
Only four months after going public, Vogenx qualifies for major Russell indexes, positioning the clinical-stage biotech to capture crucial passive institutional investment as FTSE Russell conducts its historic December reconstitution.
Galderma Targets Accelerated Expansion as U.S. Wrinkle Treatment Filing Approaches
Zurich, Thursday, 19 November 2026.
Galderma signaled sustained growth through 2027, driven by international expansion, selective acquisitions, and plans to file its Botox competitor, Relfydess, in the United States in early 2027.